MSK has many doctors and scientists who are studying the best ways to prevent graft-versus-host disease (GVHD) from developing, as well as to treat it when it does occur.
Much of this research is focused on the microbiota. This is the community of organisms that live in the body, especially in the gut. Studies have indicated that having a disruption of the microbiota increases the chances of developing GVHD.
Our experts can help determine which clinical trials are right for you. The following clinical trials for GVHD are currently enrolling new patients. To learn more about a particular study, choose from the list below.